A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

"We were surprised that a higher proportion of life was associated with a higher risk of incident multiple sclerosis in immigrants because multiple sclerosis is often thought to be a predominant ...